CURADEV PHARMA PVT LTD

CURADEV PHARMA PVT LTD Company Introduction

CURADEV PHARMA PVT LTD is an Indian drug discovery and development company based in India.

Nature of Business:

Curadev Pharma is primarily a research and development (R&D) company focused on discovering and developing new chemical entities (NCEs) for the treatment of intractable diseases. Their work involves advanced scientific research, preclinical development, and early-stage clinical development of novel drug candidates across various therapeutic areas, including oncology and inflammatory diseases. They operate with state-of-the-art research facilities where they synthesize and evaluate potential drug molecules.

Classification:

Curadev Pharma is neither a traditional large-scale manufacturing factory for commercial pharmaceutical products nor a trader. It is a specialized drug discovery and development company that produces intellectual property and early-stage drug candidates through extensive research and scientific processes.

The company CURADEV PHARMA PVT LTD is primarily a drug discovery and development company. They focus on identifying and developing novel small molecule drugs for various therapeutic areas. Their "products" are drug candidates in different stages of preclinical and clinical development, which are typically licensed to larger pharmaceutical companies for further development, manufacturing, and commercialization. They do not directly manufacture or sell finished pharmaceutical products to the market.

Their key pipeline candidates, which represent their "products" in the context of drug discovery, include:

CD1531: A small molecule STING agonist, primarily for oncology.

CD1804: A small molecule targeting an undisclosed target in oncology.

CD1702: A small molecule targeting an undisclosed target in immunology.

Other preclinical candidates in areas such as oncology, inflammation, and immunology.